JP2025121900A5 - - Google Patents

Info

Publication number
JP2025121900A5
JP2025121900A5 JP2025061960A JP2025061960A JP2025121900A5 JP 2025121900 A5 JP2025121900 A5 JP 2025121900A5 JP 2025061960 A JP2025061960 A JP 2025061960A JP 2025061960 A JP2025061960 A JP 2025061960A JP 2025121900 A5 JP2025121900 A5 JP 2025121900A5
Authority
JP
Japan
Prior art keywords
lipase
recombinant
pharmaceutical composition
composition
recombinant lipase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025061960A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025121900A (ja
Filing date
Publication date
Priority claimed from JP2022513058A external-priority patent/JP7699107B2/ja
Application filed filed Critical
Publication of JP2025121900A publication Critical patent/JP2025121900A/ja
Publication of JP2025121900A5 publication Critical patent/JP2025121900A5/ja
Pending legal-status Critical Current

Links

JP2025061960A 2019-08-30 2025-04-03 操作されたリパーゼ改変体 Pending JP2025121900A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962894019P 2019-08-30 2019-08-30
US62/894,019 2019-08-30
JP2022513058A JP7699107B2 (ja) 2019-08-30 2020-08-28 操作されたリパーゼ改変体
PCT/US2020/048405 WO2021041809A1 (en) 2019-08-30 2020-08-28 Engineered lipase variants

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022513058A Division JP7699107B2 (ja) 2019-08-30 2020-08-28 操作されたリパーゼ改変体

Publications (2)

Publication Number Publication Date
JP2025121900A JP2025121900A (ja) 2025-08-20
JP2025121900A5 true JP2025121900A5 (enExample) 2025-10-02

Family

ID=74680918

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022513058A Active JP7699107B2 (ja) 2019-08-30 2020-08-28 操作されたリパーゼ改変体
JP2025061960A Pending JP2025121900A (ja) 2019-08-30 2025-04-03 操作されたリパーゼ改変体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022513058A Active JP7699107B2 (ja) 2019-08-30 2020-08-28 操作されたリパーゼ改変体

Country Status (12)

Country Link
US (2) US11987823B2 (enExample)
EP (2) EP4022049B1 (enExample)
JP (2) JP7699107B2 (enExample)
KR (1) KR20220106738A (enExample)
CN (2) CN115175995B (enExample)
AU (1) AU2020336468B2 (enExample)
BR (1) BR112022003705A2 (enExample)
CA (1) CA3152763A1 (enExample)
ES (1) ES3007439T3 (enExample)
IL (1) IL290978A (enExample)
MX (1) MX2022002473A (enExample)
WO (1) WO2021041809A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102897514B1 (ko) * 2022-03-31 2025-12-08 동아대학교 산학협력단 꿀벌 유래 지질분해 효소 및 이의 용도
CN118185905B (zh) * 2024-05-20 2024-07-26 中国海洋大学 脂肪酶Lip1897-H106W及其应用

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59169891A (ja) 1983-03-16 1984-09-25 Konishiroku Photo Ind Co Ltd 光学的情報記録媒体の製造方法
SE9001985D0 (sv) 1990-06-01 1990-06-01 Astra Ab New chemical products
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US20060257890A1 (en) 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
ATE294871T1 (de) 1994-06-30 2005-05-15 Novozymes Biotech Inc Nicht-toxisches, nicht-toxigenes, nicht- pathogenes fusarium expressionssystem und darin zu verwendende promotoren und terminatoren
FR2733249B1 (fr) * 1995-04-20 1997-06-06 Biocem Lipase gastrique de chien recombinante et polypeptides derives produits par les plantes, leurs procedes d'obtention et leurs utilisations
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US6506602B1 (en) 1996-03-25 2003-01-14 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US7148054B2 (en) 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
EP1717322B1 (en) 1997-01-17 2012-07-18 Codexis Mayflower Holdings, LLC Evolution of whole cells and organisms by recursive sequence recombination
WO1998031816A1 (en) 1997-01-17 1998-07-23 Regents Of The University Of Minnesota Dna molecules and protein displaying improved triazine compound degrading ability
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
IL136574A0 (en) 1997-12-08 2001-06-14 California Inst Of Techn A method for forming a polynucleotide of desired properties
CA2326835A1 (en) 1998-04-02 1999-10-14 Tellus Genetic Resources, Inc. A method for obtaining a plant with a genetic lesion in a gene sequence
CN1314911A (zh) 1998-05-01 2001-09-26 麦克西根股份有限公司 用dna改组优化害虫抗性基因
JP2002517995A (ja) 1998-06-17 2002-06-25 マキシジェン, インコーポレイテッド 所望の特性を有するポリヌクレオチドを生成するための方法
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
EP1104459A1 (en) 1998-08-12 2001-06-06 Maxygen, Inc. Dna shuffling of monooxygenase genes for production of industrial chemicals
AU6510799A (en) 1998-10-07 2000-04-26 Maxygen, Inc. Dna shuffling to produce nucleic acids for mycotoxin detoxification
EP1129184A1 (en) 1998-11-10 2001-09-05 Maxygen, Inc. Modified adp-glucose pyrophosphorylase for improvement and optimation of plant phenotypes
JP4221100B2 (ja) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 半導体装置
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US8457903B1 (en) 1999-01-19 2013-06-04 Codexis Mayflower Holdings, Llc Method and/or apparatus for determining codons
US7873477B1 (en) 2001-08-21 2011-01-18 Codexis Mayflower Holdings, Llc Method and system using systematically varied data libraries
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
US20070065838A1 (en) 1999-01-19 2007-03-22 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
JP2002534965A (ja) 1999-01-19 2002-10-22 マキシジェン, インコーポレイテッド 所望の特徴を有する文字ストリング、ポリヌクレオチドおよびポリペプチドを作製するための方法
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
IL144657A0 (en) 1999-02-11 2002-06-30 Maxygen Inc High throughput mass spectrometry
AU3391900A (en) 1999-03-05 2000-09-21 Maxygen, Inc. Encryption of traits using split gene sequences
US6703240B1 (en) 1999-04-13 2004-03-09 Maxygar, Inc. Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6519065B1 (en) 1999-11-05 2003-02-11 Jds Fitel Inc. Chromatic dispersion compensation device
US6686515B1 (en) 1999-11-23 2004-02-03 Maxygen, Inc. Homologous recombination in plants
SG121902A1 (en) 2000-01-11 2006-05-26 Maxygen Inc Integrated systems for diversity generation and screening
US20010046493A1 (en) 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
AU4964101A (en) 2000-03-30 2001-10-15 Maxygen Inc In silico cross-over site selection
AU2001249811B2 (en) 2000-04-03 2006-06-08 Maxygen, Inc. Subtilisin variants
US6858422B2 (en) 2000-07-13 2005-02-22 Codexis, Inc. Lipase genes
US6862271B2 (en) 2002-02-26 2005-03-01 Qualcomm Incorporated Multiple-input, multiple-output (MIMO) systems with multiple transmission modes
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
EP2315145B1 (en) 2002-03-01 2015-11-25 Codexis Mayflower Holdings, LLC Methods, systems, and software for identifying functional biomolecules
US7747391B2 (en) 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
WO2003078583A2 (en) 2002-03-09 2003-09-25 Maxygen, Inc. Optimization of crossover points for directed evolution
US7020762B2 (en) 2002-12-24 2006-03-28 Intel Corporation Method and apparatus for determining a dynamic random access memory page management implementation
US7303904B2 (en) * 2003-01-30 2007-12-04 Council Of Scientific & Industrial Research Stable gene variants of lipases
CA2515583C (en) 2003-03-07 2015-07-14 Diversa Corporation Hydrolases, nucleic acids encoding them and methods for making and using them
US7629157B2 (en) 2003-08-11 2009-12-08 Codexis, Inc. Ketoreductase polypeptides and related polynucleotides
DK1809320T3 (da) 2004-10-14 2010-11-15 Cystic Fibrosis Foundation The Præparater indeholdende lipase, protease og amylase til behandling af pankreatisk insufficiens
EP1869174B1 (en) 2005-03-10 2015-02-18 BASF Enzymes LLC Lyase enzymes, nucleic acids encoding them and methods for making and using them
US7531341B1 (en) 2006-06-12 2009-05-12 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US7534595B2 (en) 2006-06-12 2009-05-19 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
KR101497159B1 (ko) 2006-06-15 2015-03-03 라보라뜨와르 메이올리 스핀들러 리파아제 생산 방법, 상기 리파아제를 생산할 수 있는 형질전환된 Yarrowia lipolytica 세포 및 그 용도
US7537923B2 (en) 2007-08-17 2009-05-26 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
WO2009102901A1 (en) 2008-02-12 2009-08-20 Codexis, Inc. Method of generating an optimized, diverse population of variants
US8504498B2 (en) 2008-02-12 2013-08-06 Codexis, Inc. Method of generating an optimized, diverse population of variants
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
ES2705694T3 (es) 2008-06-13 2019-03-26 Codexis Inc Método de síntesis de variantes de polinucleótidos
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
CA2747703C (en) 2009-01-06 2021-06-15 Curemark Llc Compositions and methods for the treatment or the prevention of infections by e. coli
BRPI0922653B8 (pt) 2009-01-29 2021-05-25 Nordmark Arzneimittel Gmbh & Co Kg uso de uma lipase bacteriana do tipo pseudomonas em solução aquosa
WO2013003290A1 (en) 2011-06-28 2013-01-03 Codexis, Inc. Protein variant generation by region shuffling
EP4062928A3 (en) 2010-02-04 2022-11-30 BioMarin Pharmaceutical Inc. Prokaryotic phenylalanine ammonia-lyases and their use for treating phenylketonuria and hyperphenylalaninemia
MY171837A (en) * 2010-09-14 2019-11-01 Univ Putra Malaysia Novel microorganisms producing thermostable lipase from oil contaminated sample and methods thereof
US20150133698A1 (en) 2012-04-20 2015-05-14 Codexis, Inc. Production of fatty alcohols from engineered microorganisms
WO2013170050A1 (en) 2012-05-11 2013-11-14 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
AU2013316124C1 (en) 2012-09-14 2022-01-06 Genomatica, Inc. Enzyme variants with improved ester synthase properties
RU2695146C2 (ru) 2013-01-31 2019-07-22 Кодексис, Инк. Способы, системы и программное обеспечение для идентификации биомолекул со взаимодействующими компонентами
CA2970638A1 (en) 2014-12-22 2016-06-30 Codexis, Inc. Human alpha-galactosidase variants
US9821613B2 (en) 2015-07-20 2017-11-21 Bendix Commercial Vehicle Systems Llc Transmitting device with antenna
DE102015114859A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Verwendung einer pharmazeutischen Zusammensetzung, enthaltend mindestens ein Verdauungsenzym, bei der künstlichen Ernährung
WO2017131927A1 (en) 2016-01-26 2017-08-03 Applied Materials, Inc. Wafer edge ring lifting solution
JP2020530267A (ja) 2017-06-30 2020-10-22 コデクシス, インコーポレイテッド T7 rnaポリメラーゼバリアント
WO2019185612A1 (en) 2018-03-26 2019-10-03 Basf Se Method of reducing soil water repellency

Similar Documents

Publication Publication Date Title
HRP20190928T1 (hr) Modificirani fenilalanin amonijak-liazni polipeptidi
JP2023507575A5 (enExample)
JP2016516428A5 (enExample)
JP2010525806A5 (enExample)
JP2023539632A5 (enExample)
JP2024028452A (ja) セリアックスプルー病を治療するための組成物および方法
RU2014139953A (ru) Способы и материалы для лечения болезни помпе
CN114032273B (zh) 一种多功能西洋参水解肽及其制备方法和应用
JP2020505942A5 (enExample)
CN113429458B (zh) 一种抑制二肽基肽酶iv功能的南极磷虾降血糖寡肽及用途
HRP20230468T1 (hr) Varijante ljudske alfa galaktozidaze
CA2666536C (en) Compositions and methods of using chondroitinase abci mutants
JP2024540358A5 (enExample)
JP2023539634A5 (enExample)
CN111909955B (zh) 重组MANNase-GLP-1及同源物的制备及应用
JP2022515742A5 (enExample)
CN101463089B (zh) 人血清白蛋白-干扰素融合蛋白及其编码基因与应用
CN120988057A (zh) 一种具有降尿酸活性的黄嘌呤氧化酶抑制肽及其应用
JP5272115B2 (ja) 経口免疫寛容を誘導するペプチド組成物及びその製造方法
JP2007516214A5 (enExample)
US20090098630A1 (en) Fusion protein, gene related to fusion protein, vector, transformants, and anti-inflammatory medicinal composition
CN104288614A (zh) 一种改善儿童厌食、偏食及促进生长发育的制剂
CN116004406A (zh) 一种重组酵母菌株及其在生物转化人参二醇型皂苷中的应用
CN100386113C (zh) 脑蛋白水解物注射剂及其制备工艺
CN117467651B (zh) 一种表达芳香族氨基酸降解酶重组多肽和重组细胞及其应用